Status:
COMPLETED
Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to Placebo
Lead Sponsor:
Khon Kaen University
Collaborating Sponsors:
Bangkok Laboratories and Cosmetics
Conditions:
Osteoarthritis, Knee Joint
Capsicum
Eligibility:
All Genders
40-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether capsaicin gel is effective in treating mild to moderate degrees of osteoarthritis of the knee in the elderly patient compared with placebo gel.
Detailed Description
Osteoarthritis (OA) is the most common form of arthritis in the population. It is characterized pathologically by both focal loss of articular cartilage and marginal and central new bone formation. OA...
Eligibility Criteria
Inclusion
- Subjects eligible for enrollment in the study must meet all of the following criteria:
- Subjects who are capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.
- Ambulatory nom pregnant females and males 40-\<80 years of age.
- Subjects who withdraw pain medication or nutritional supplements for symptom relief for knee OA for a total of at least 15 days before screening visit 0.
- Pain at or below 80 mm on a 100 mm VAS in the index knee.
- A documented diagnosis of OA of the knee, or meeting American College of Rheumatology (ACR) clinical criteria for classification of idiopathic (primary) OA for at least 6 months prior to screening. If OA is presented in both knees the investigator will identify which knee will be X-rayed for study entry, with preference for the knee with more severe pain (\<80mm VAS).
- Has documented radiographic evidence of OA of the knee from the screening Visit radiograph of grade 2 or 3 according to Kellgren and Lawrence Radiographic Grading.
- Subjects with baseline minimum joint space width in the medial compartment of the index knee of \> 1.5 mm at Baseline, measured from radiographs using the MTP view.
- Subjects with baseline minimum joint space width in the lateral compartment of the index knee of \> 2.5 mm at Baseline, measured from radiographs using the MTP view.
- Subject is able to understand and complete pain/function, global arthritis evaluation, and health outcome assessment.
Exclusion
- Subjects with any of the following criteria must not be enrolled in the study:
- Subjects with history of hypersensitivity to capsaicin.
- Subjects with skin lesion at the index knee.
- A history of lower extremity surgery within 6 months prior to screening V0.
- Significant prior injury to the index knee within 12 months prior to screening V0.
- Disease of the spine or other lower extremity joints of sufficient degree to affect the index knee.
- Treatment with other drugs potentially affecting bone or cartilage metabolism as described below:
- chronic systematic corticosteroids
- hyaluronan injection into the index knee with in the previous 6 months.
- Diacerin treatment within the last 12 months.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00471055
Start Date
June 1 2007
End Date
December 1 2007
Last Update
July 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weerachai Kosuwon
Khon Kaen University, Changwat Khon Kaen, Thailand, 40002